First published online October 25, 2007
Stem Cells
Vol. 26 No.
1
January 2008, pp.
279
-289
doi:10.1634/stemcells.2007-0454; www.StemCells.com
© 2008 AlphaMed Press
TRANSLATIONAL AND CLINICAL RESEARCH |
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
Francesco Liottaa,
Roberta Angelia,
Lorenzo Cosmia,
Lucia Filìa,
Cinzia Manuellia,
Francesca Frosalia,
Benedetta Mazzinghia,
Laura Maggia,
Annalisa Pasinib,
Veronica Lisib,
Veronica Santarlascia,
Lara Consolonia,
Maria Lucia Angelottia,
Paola Romagnania,
Paola Parronchia,
Mauro Kramperab,
Enrico Maggia,
Sergio Romagnania,
Francesco Annunziatoa
aExcellence Center of the University of Florence De Novo Therapy, Florence, Italy;
bSection of Haematology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
Key Words. Tolerance • Suppression • Anergy • Stem cells • T cells • Notch
Correspondence: Sergio Romagnani, Ph.D., Department of Internal Medicine, University of Florence, Viale Morgagni 85, Firenze 50134, Italy. Telephone: 39-055-413663; Fax: 39-055-4271500; e-mail: s.romagnani{at}dmi.unifi.it
Received June 15, 2007;
accepted for publication October 15, 2007.
First published online in STEM CELLS EXPRESS October 25, 2007.
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) are multipotent, nonhemopoietic progenitors that also possess regulatory activity on immune effector cells through different mechanisms. We demonstrate that human BM-derived MSCs expressed high levels of Toll-like receptors (TLRs) 3 and 4, which are both functional, as shown by the ability of their ligands to induce nuclear factor
B (NF-
B) activity, as well as the production of interleukin (IL)-6, IL-8, and CXCL10. Of note, ligation of TLR3 and TLR4 on MSCs also inhibited the ability of these cells to suppress the proliferation of T cells, without influencing their immunophenotype or differentiation potential. The TLR triggering effects appeared to be related to the impairment of MSC signaling to Notch receptors in T cells. Indeed, MSCs expressed the Notch ligand Jagged-1, and TLR3 or TLR4 ligation resulted in its strong downregulation. Moreover, anti-Jagged-1 neutralizing antibody and N[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT), an inhibitor of Notch signaling, hampered the suppressive activity of MSCs on T-cell proliferation. These data suggest that TLR3 and TLR4 expression on MSCs may provide an effective mechanism to block the immunosuppressive activity of MSCs and therefore to restore an efficient T-cell response in the course of dangerous infections, such as those sustained by double-stranded RNA viruses or Gram-negative bacteria, respectively.
Disclosure of potential conflicts of interest is found at the end of this article.

Copyright © 2008 by AlphaMed Press.